申请人:MISSION THERAPEUTICS LIMITED
公开号:US10669234B2
公开(公告)日:2020-06-02
The present invention relates to novel compounds and method for the manufacture of inhibitors of deubiquitylating enzymes (DUBs). In particular, the invention relates to the inhibition of ubiquitin C-terminal hydrolase L1 (UCHL1) and ubiquitin C-terminal hydrolase 30 or ubiquitin specific peptidase 30 (USP30). The invention further relates to the use of DUB inhibitors in the treatment of cancer and conditions involving mitochondrial dysfunction. Compounds of the invention include compounds having the formula (I) or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8 and R9 are as defined herein.
本发明涉及新型化合物和去泛素化酶(DUB)抑制剂的制造方法。特别是,本发明涉及对泛素 C 端水解酶 L1(UCHL1)和泛素 C 端水解酶 30 或泛素特异性肽酶 30(USP30)的抑制。本发明进一步涉及 DUB 抑制剂在治疗癌症和涉及线粒体功能障碍的疾病中的用途。本发明的化合物包括具有式(I)的化合物或其药学上可接受的盐,其中R1、R2、R3、R4、R5、R6、R7、R8和R9如本文所定义。